Literature DB >> 7278085

Metabolites of glucose in the blood of patients with renal failure.

C Heierli, H Thölen.   

Abstract

The blood concentrations of pyruvate and of some of its metabolites and the red cell 2,3-diphosphoglycerate concentration were compared with the severity of uraemia in 103 patients with renal failure. In chronic renal failure 2,3-butylene glycol was distinctly elevated, and a positive linear correlation (2p Less Than 0.001) with the urea was found. The values were even higher in corresponding patients with uraemic pericarditis, but,--taking into account their relation to the urea--,they were not elevated in acute renal failure. Acetaldehyde, acetoin and acetate behaved in part likewise. Severe uraemia, which clinically was demonstrated by uraemic pericarditis, was characterized biochemically, without regard to the urea, by very elevated values of 2,3-butylene glycol and acetaldehyde and of the pyruvate: lactate ratio. In addition, the chronic patients who were not undergoing regular haemodialysis, did not show the expected rise of 2,3-diphospho-glycerate along with progressive anaemia. The data suggest that the uraemic state is characterized by the impairment of the oxidative glucose metabolism between pyruvate and the tricarbonic acid cycle more precisely than by the blood urea.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7278085     DOI: 10.1007/BF01695897

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  [On the pathogenesis of the uremia syndrome. Pyruvic acid, acetoin and 2,3-butyleneglycol in the blood of patients with kidney and liver diseases].

Authors:  H THOLEN; F BIGLER; A HEUSLER; W STAUFFACHER; H STAUB
Journal:  Experientia       Date:  1962-10-15

2.  Glucose metabolism in human erythrocytes from normal and fava bean-sensitive subjects.

Authors:  G FORNAINI; G LEONCINI; L LUZZATTO; G SEGNI
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

3.  [On the pathogenesis of uremia syndromes. I. The content of acetoin and 2,3-butyleneglycol in the blood of uremic patients].

Authors:  H THOELEN; F BIGLER; H STAUB
Journal:  Pathol Microbiol (Basel)       Date:  1961

4.  [Blood and urinary keto acids: analytic study; identification of new hydrazones; clinical applications].

Authors:  G BISERTE; B DASSONVILLE
Journal:  Clin Chim Acta       Date:  1956-01       Impact factor: 3.786

5.  Blood pyruvic-acid and alpha-ketoglutaric-acid levels in liver disease and hepatic coma.

Authors:  A M DAWSON; J DE GROOTE; W S ROSENTHAL; S SHERLOCK
Journal:  Lancet       Date:  1957-02-23       Impact factor: 79.321

6.  A simple spectrophotometric method for the determination of acetaldehyde in blood.

Authors:  T N BURBRIDGE; C H HINE; A F SCHICK
Journal:  J Lab Clin Med       Date:  1950-06

7.  Reduced nicotinamide adenine dinucleotide-linked analysis of 2,3-diphosphoglyceric acid: spectrophotometric and fluorometric procedures.

Authors:  A S Keitt
Journal:  J Lab Clin Med       Date:  1971-03

8.  The oxyhemoglobin dissociation curve in health and disease. Role of 2,3-diphosphoglycerate.

Authors:  H M Thomas; S S Lefrak; R S Irwin; H W Fritts; P R Caldwell
Journal:  Am J Med       Date:  1974-09       Impact factor: 4.965

9.  Kinetics of infused acetate and effect on plasma pyruvate and lipid concentrations in uremic and non-uremic dogs.

Authors:  R J Morin; L S Guo; S J Rorke; W D Davidson
Journal:  J Dial       Date:  1977

10.  Acetate intolerance in chronic uremic patients.

Authors:  G F Guarnieri; R Carretta; G Toigo; L Campanacci
Journal:  Nephron       Date:  1979       Impact factor: 2.847

View more
  1 in total

1.  Utility of SIFT-MS to evaluate volatile organic compounds in nephropathic patients' breath.

Authors:  Annalisa Romani; Giulia Marrone; Roberto Celotto; Margherita Campo; Chiara Vita; Carlo Chiaramonte; Andrea Carretta; Nicola Di Daniele; Annalisa Noce
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.